[1]李和恩,史超强,曲超.低能量810 nm激光治疗黄斑区中心性浆液性脉络膜视网膜病变的安全性及疗效[J].眼科新进展,2020,40(1):031-33.[doi:10.13389/j.cnki.rao.2020.0007]
　LI Heen,SHI Chaoqiang,QU Chao.Safety and efficacy of low-energy 810 nm laser in treatment of central serous chorioretinopathy in macular area[J].Recent Advances in Ophthalmology,2020,40(1):031-33.[doi:10.13389/j.cnki.rao.2020.0007]
点击复制

低能量810 nm激光治疗黄斑区中心性浆液性脉络膜视网膜病变的安全性及疗效/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
40卷
期数:
2020年1期
页码:
031-33
栏目:
应用研究
出版日期:
2020-01-05

文章信息/Info

Title:
Safety and efficacy of low-energy 810 nm laser in treatment of central serous chorioretinopathy in macular area
文章编号:
20200107
作者:
李和恩; 史超强; 曲超
646000　四川省泸州市，西南医科大学临床医学院（李和恩，曲超）；610000　四川省成都市，四川省人民医院新津分院（李和恩）；610000　四川省成都市，电子科技大学（史超强）；610000　四川省成都市，四川省人民医院眼科（曲超）
Author(s):
LI Heen1; 2; SHI Chaoqiang3; QU Chao1; 4
1.Clinical Medical College of Southwest Medical University,Luzhou 646000,Sichuan Province,China
2.Xinjin Hospital of Sichuan Provincial People’s Hospital,Chengdu 610000,Sichuan Province,China
3.University of Electronic Science and Technology of China,Chengdu 610000,Sichuan Province,China
4.Department of Ophthalmology,Sichuan Provincial People’s Hospital,Chengdu 610000,Sichuan Province,China
Corresponding author:QU Chao,E-mail:6477835@qq.com
关键词:
光生物调节作用; 中心性浆液性脉络膜视网膜病变; 荧光素眼底血管造影; 吲哚菁绿血管造影
Keywords:
photobiomodulation; central serous chorioretinopathy; fundus fluorescein angiography; indocyanine green angiography
分类号:
R774
DOI:
10.13389/j.cnki.rao.2020.0007
文献标志码:
A
摘要:
目的　探讨低能量810 nm激光治疗黄斑区中心性浆液性脉络膜视网膜病变（central serous chorioretinopathy，CSC）的安全性和疗效。方法　选取在我院确诊的黄斑区CSC单眼发病患者38例，随机分为2组：药物治疗组18例18眼，激光治疗组20例20眼。药物治疗组采用口服云南白药胶囊和维生素片；激光治疗组采用口服药物（云南白药胶囊和维生素片）和810 nm激光联合治疗。于治疗前及治疗后对患者行最佳矫正视力、视野、黄斑区OCT和眼底血管造影检查，统计分析各指标。结果　药物治疗组患眼治疗前最佳矫正视力为4.91±0.16，治疗后为4.92±0.16，治疗前后比较，差异无统计学意义（P>0.05）。激光治疗组患眼治疗前最佳矫正视力为4.93±0.12，治疗后为4.98±0.06，治疗前后比较，差异亦无统计学意义（P>0.05）。治疗前与治疗后药物治疗组与激光治疗组患眼最佳矫正视力组间比较，差异均无统计学意义（均为P>0.05）。治疗后3个月，激光治疗组患眼总体偏差视敏度为（-1.03±0.86）dB，与对侧眼总体偏差视敏度［（-0.85±0.72）dB］相比，差异无统计学意义（t=0.83，P=0.42）；与患眼治疗前总体偏差视敏度［（-3.75±3.28）dB］相比，差异有统计学意义（t=4.53，P<0.05）。治疗3个月后复查，药物治疗组8眼治愈，治愈率为44.5%；激光治疗组17眼治愈，治愈率为85.0%，激光治疗组治愈率明显高于药物治疗组，差异有统计学意义（P<0.05）。结论　低能量810 nm激光治疗黄斑区CSC是安全有效的。
Abstract:
Objective　To investigate the safety and clinical efficacy of low-energy 810 nm laser in the treatment of patients with central serous chorioretinopathy （CSC） in macular area.Methods　Totally 38 patients （38 eyes） diagnosed with CSC in macular area were enrolled in the study，and randomly divided into 2 groups：18 patients （18 eyes） in the drug treatment group，and 20 patients （20 eyes） in the laser treatment group.Patients in drug treatment group received oral administration of Yunnan Baiyao Capsules and Vitamin Tablets，and those in laser treatment group received combined treatment of oral drugs （Yunnan Baiyao Capsules and Vitamin Tablets） and 810 nm laser.The best corrected visual acuity （BCVA），visual field and macular OCT were detected，and fundus angiography was performed before and after treatment.All data were statistically analyzed.Results　For affected eyes in the drug treatment group，BCVA was 4.91±0.16 before treatment and 4.92±0.16 after treatment，and there was no statistical difference before and after treatment （P>0.05）.For affected eyes in the laser treatment group，BCVA was 4.93±0.12 before treatment and 4.98±0.06 after treatment，and there was no statistical difference before and after treatment （P>0.05）.Comparing with laser treatment group,no significant difference was found in BCVA of affected eyes for drug treatment group before or after treatment （all P>0.05）.Three months after treatment，the total deviant visual acuity was （-1.03±0.86）dB for affected eyes and （-0.85±0.72）dB for contralateral eyes in laser treatment group，which had no statistical difference （t=0.83，P=0.42）；the total visual acuity was （-3.75±3.28）dB for affected eyes before treatment，which had statistical difference with that of affected eyes 3 months after treatment （t=4.53，P<0.01）.During re-examination 3 months after treatment,there were 8 eyes cured in drug treatment group and 17 eyes cured in laser treatment group,with cure rates of 44.5% and 85.0%,respectively.The laser treatment group had a statistically higher cure rate than that in drug treatment group （P<0.05）.Conclusion　Low-energy 810 nm laser is safe and effective for the treatment of CSC in the macular area.

参考文献/References:

［1］　FEKIH O，MABROUK S，ZGOLLI M H，BAKIR K，ZGHAL I，NACEF L.Choroidal neovascularization following argon laser photocoagulation for central serous chorioretinopathy［J］.Tunis Med，2019，97（1）：157-162.
［2］　游慧，张学东.激光治疗中心性浆液性脉络膜视网膜病变的新进展［J］.眼科新进展，2016，36（3）：297-300.
YOU H，ZHANG X D.Recent advances in laser for central serous chorioretinopathy［J］.Rec Adv Ophthalmol，2016，36（3）：297-300.
［3］　张承芬.眼底病学［M］.第2版.北京：人民卫生出版社，2010：416.
ZHANG C F.Diseases of ocular fundus［M］.2nd ed.Beijing：People’s Medical Publishing House，2010：416.
［4］　GLKA S，SAHIN .Current therapeutic approaches to chronic central serous chorioretinopathy［J］.Turk J Ophthalmol，2019，49（1）：30-39.
［5］　CARNEIRO A M C，POIANI G C，ZANINNOTO A L，LAZO OSORIO R，OLIVEIRA M L，PAIVA W S，et al.Transcranial photobiomodulation therapy in the cognitive rehabilitation of patients with cranioencephalic trauma［J］.Photobiomodul Photomed Laser Surg，2019，37（10）：657-666.
［6］　AO J，WOOD J P，CHIDLOW G，GILLIES M C，CASSON R J.Retinal pigment epithelium in the pathogenesis of age-related macular degeneration and photobiomodulation as a potential therapy?［J］.Clin Exp Ophthalmol，2018，46（6）：670-686.
［7］　SULZBACHER F，SCHTZE C，BURGMLLER M，VCSEI-MARLOVITS P V，WEINGESSEL B.Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy （CSC） diagnosed by swept source optical coherence tomography angiography（SS OCTA）［J］.Graefes Arch Clin Exp Ophthalmol，2019，257（8）：1581-1590.
［8］　UYAMA M，MATSUNAGA H，MATSUBARA T，FUKUSHIMA I，TAKAHASHI K，NISHIMURA T.Indocyanine green angiography and pathophysiology of multifocal posterior pigment epitheliopathy［J］.Retina，1999，19（1）：12-21.
［9］　NICHOLSON B，NOBLE J，FOROOGHIAN F.Central serous chorioretinopathy：update on pathophysiology and treatment［J］.Surv Ophthalmol，2013，58（2）：103-126.
［10］　MARUKO I.Evaluation of the choroid in central serous chorioretinopathy［J］.Nippon Ganka Gakkai Zasshi，2012，116（11）：1062-1079.
［11］　彭锡嘉，王波，苏兰萍，王登廷，郝保安，高琛.应用荧光素吲哚青绿同步眼底造影对中心性浆液性视网膜病变眼底微循环改变的观察［J］.眼科新进展，2009，29（1）：38-42.
PENG X J，WANG B，SU L P，WANG D T，HAO B A，GAO C.Changes of ocular fundus microcirculation using simultaneous fluorescein and indocyanine green angiography for central serous chorioretinopathy［J］.Rec Adv Ophthalmol，2009，29（1）：38-42.
［12］　黎晓新，赵明威.我国近五年眼底病诊疗技术进展［J］.中华眼科杂志，2010，46（10）：900-905.
LI X X，ZHAO M W.Up-to-date development of diagnosis and treatment technology of ocular fundus diseases in the past 5 years in China［J］.Chin J Ophthalmol，2010，46（10）：900-905.
［13］　GIUDICE G L，de BELVIS V，TAVOLATO M，TAVOLATO M，GALAN A.Large-spot subthreshold transpupillary thermotherapy for chronic serous macular detachment［J］.Clin Ophthalmol，2011，5：355-360.
［14］　赵辉.低能量近红外光治疗眼底病安全参数的研究［D］.成都：电子科技大学，2017：2-10.
ZHAO H.The study of low-level near-infrared light parameters in the treatment of retinal diseases［D］.Chengdu：University of Electronic Science and Technology of China，2017：2-10.

相似文献/References:

[1]刘卫华 杨新怀 黄勤 聂鑫 覃旭方 全婵娟.OCT与FFA在中心性浆液性脉络膜视网膜病变检查中的应用比较[J].眼科新进展,2013,33(9):000.
[2]张鹏 王雨生 胡丹 王海燕 张自峰.561nm 激光光凝治疗中心性浆液性脉络膜视网膜病变[J].眼科新进展,2013,33(3):000.
[3]童桂芳 周琼.中心性浆液性脉络膜视网膜病变的研究进展[J].眼科新进展,2013,33(3):000.
[4]唐风雷 朱珊梅 周建强 于忠兴 朱太春 谢秀雯 蒋星 陆人杰.中心性浆液性脉络膜视网膜病变的临床研究与治疗评价[J].眼科新进展,2013,33(11):000.
[5]王志立 李晓华 李士清 董应丽 李萍. 慢性迁延性中心性浆液性脉络膜视网膜病变的两种自发荧光特征[J].眼科新进展,2014,34(2):151.
[6]徐建锋 叶瑞珍 李贵洲 蔡泽煌. 低能量TTT治疗中心凹下渗漏型CSC的临床研究[J].眼科新进展,2014,34(3):239.
[7]黄丽华,陈素芳,邵毅,等. 非诺贝特治疗中心性浆液性脉络膜视网膜病变的临床研究[J].眼科新进展,2014,34(4):333.[doi:10.13389/j.cnki.rao.2014.0090]
[8]林杜生,张贵华,陈浩宇,等. 频域OCT在急性Vogt-小柳原田病和急性中心性浆液性脉络膜视网膜病变鉴别诊断中的应用[J].眼科新进展,2015,35(6):557.[doi:10.13389/j.cnki.rao.2015.0151]
　LIN Du-Sheng,ZHANG Gui-Hua,CHEN Hao-Yu,et al. Distinguishing acute Vogt-Koyanagi-Harada disease from acute central serous chorioretinopathy with spectral domain OCT[J].Recent Advances in Ophthalmology,2015,35(1):557.[doi:10.13389/j.cnki.rao.2015.0151]
[9]童桂芳,周琼,邵毅. 急性中心性浆液性脉络膜视网膜病变FFA与频域OCT图像对比研究[J].眼科新进展,2015,35(8):735.[doi:10.13389/j.cnki.rao.2015.0201]
　TONG Gui-Fang,ZHOU Qiong,SHAO Yi. A comparative study on image of FFA and FD-OCT in acute central serous chorioretinopathy[J].Recent Advances in Ophthalmology,2015,35(1):735.[doi:10.13389/j.cnki.rao.2015.0201]
[10]游慧,张学东.激光治疗中心性浆液性脉络膜视网膜病变的新进展[J].眼科新进展,2016,36(3):297.[doi:10.13389/j.cnki.rao.2016.0081]
　YOU Hui,ZHANG Xue-Dong.Recent advances in laser for central serous chorioretinopathy[J].Recent Advances in Ophthalmology,2016,36(1):297.[doi:10.13389/j.cnki.rao.2016.0081]

备注/Memo

备注/Memo:
国家自然科学基金资助（编号：81570848）
更新日期/Last Update: 2020-01-05